Engineering living therapeutics and diagnostics: A new frontier in human health

Kelly, 2020, Living therapeutics: the next frontier of precision medicine, ACS Synth Biol, 9, 3184, 10.1021/acssynbio.0c00444 Zhou, 2022, Engineered bacteria as drug delivery vehicles: principles and prospects, Engineering Microbiology, 10.1016/j.engmic.2022.100034 Pedrolli, 2019, Engineering microbial living therapeutics: the synthetic biology toolbox, CelPress, 37, 100 Huang, 2022, Transcriptional programming in a Bacteroides consortium, Nat Commun, 13, 3901, 10.1038/s41467-022-31614-8 Nielsen, 2016, Genetic circuit design automation, Science, 352, 10.1126/science.aac7341 Vaaben, 2022, Characterization of eight bacterial biosensors for microbial diagnostic and therapeutic applications, ACS Synth Biol, 11, 4184, 10.1021/acssynbio.2c00491 Harimoto, 2022, A programmable encapsulation system improves delivery of therapeutic bacteria in mice, Nat Biotechnol, 40, 1259, 10.1038/s41587-022-01244-y Higashikuni, 2017, Advancing therapeutic applications of synthetic gene circuits, Curr Opin Biotechnol, 47, 133, 10.1016/j.copbio.2017.06.011 Rondon, 2019, Transcriptional programming using engineered systems of transcription factors and genetic architectures, Nat Commun, 10 Qin, 2023, Genetic programming by nitric oxide-sensing gene switch system in tumor-targeting bacteria, Biosensors, 13, 266, 10.3390/bios13020266 Short, 2023, Next generation synthetic memory via intercepting recombinase function, Nat Commun, 14 Benítez-Chao, 2022, Design and in silico analysis of a whole-cell biosensor able to kill methicillin-resistant, Staphylococcus aureus. Biotechnology and Applied Biochemistry, 69, 1373, 10.1002/bab.2210 Lynch, 2023, Engineered Escherichia coli for the in situ secretion of therapeutic nanobodies in the gut, Cell Host Microbe, 31, 634, 10.1016/j.chom.2023.03.007 Chabloz, 2020, Salmonella-based platform for efficient delivery of functional binding proteins to the cytosol, Commun Biol, 3, 342, 10.1038/s42003-020-1072-4 Mimee, 2015, Programming a human commensal bacterium, Bacteroides thetaiotaomicron to sense and respond to stimuli in the murine gut microbiota, Cell Systems, 1, 62, 10.1016/j.cels.2015.06.001 Fan, 2018, Bacteria-mediated tumor therapy utilizing photothermally-controlled TNF-α expression via oral administration, Nano Lett, 18, 2373, 10.1021/acs.nanolett.7b05323 Liu, 2021, Metabolically engineered bacteria as light-controlled living therapeutics for anti-angiogenesis tumor therapy, Mater Horiz, 8, 1454, 10.1039/D0MH01582B Abedi, 2022, Ultrasound-controllable engineered bacteria for cancer immunotherapy, Nat Commun, 13 Hurt, 2023, Genomically mined acoustic reporter genes for real-time in vivo monitoring of tumors and tumor-homing bacteria, Nat Biotechnol, 41, 919, 10.1038/s41587-022-01581-y Lalwani, 2021, Optogenetic control of the lac operon for bacterial chemical and protein production, Nat Chem Biol, 17 Li, 2020, A single-component light sensor system allows highly tunable and direct activation of gene expression in bacterial cells, Nucleic Acids Res, 48, e33, 10.1093/nar/gkaa044 Zhang, 2022, Upconversion optogenetic engineered bacteria system for time-resolved imaging diagnosis and light-controlled cancer therapy, ACS Appl Mater Interfaces, 14, 46351, 10.1021/acsami.2c14633 Ohlendorf, 2012, From dusk till dawn: one-plasmid systems for light-regulated gene expression, J Mol Biol, 416, 534, 10.1016/j.jmb.2012.01.001 Terrell, 2021, Bioelectronic control of a microbial community using surface-assembled electrogenetic cells to route signals, Nat Nanotechnol, 16, 688, 10.1038/s41565-021-00878-4 Atkinson, 2022, Real-time bioelectronic sensing of environmental contaminants, Nature, 611, 548, 10.1038/s41586-022-05356-y Mimee, 2018, An ingestible bacterial-electronic system to monitor gastrointestinal health, Science, 360, 915, 10.1126/science.aas9315 An, 2020, Programming living glue systems to perform autonomous mechanical repairs, Matter, 3, 2080, 10.1016/j.matt.2020.09.006 Nguyen, 2021, Wearable materials with embedded synthetic biology sensors for biomolecule detection, Nat Biotechnol, 39, 1366, 10.1038/s41587-021-00950-3 Brody, 2020, The gut microbiome, Nature, 577, 10.1038/d41586-020-00194-2 Xiaodi Chen, 2021, The female vaginal microbiome in health and bacterial vaginosis, Front Cell Infect Microbiol, 11 Pedro Viera-Baptista, 2022, The vaginal microbiome: V. Therapeutic modalities of vaginal microbiome engineering and research challenges, J Low Genit Tract Dis, 26 Borges, 2014, The role of lactobacilli and probiotics in maintaining vaginal health, Arch Gynecol Obstet, 289, 479, 10.1007/s00404-013-3064-9 Chee, 2020, Vaginal microbiota and the potential of Lactobacillus derivatives in maintaining vaginal health, Microb Cell Factories, 19 Katarzyna, 2019, Comparison of eight Lactobacillus species, for delivery of surface-displayed mycobacterial antigen, Vaccine, 37 Benjamin, 2021, The gut microbiome: what every gastroenterologist needs to know, Frontline Gastroenterol, 12, 118, 10.1136/flgastro-2019-101376 De Vos, 2022, Gut microbiome and health: mechanistic insights, Gut, 71, 1020, 10.1136/gutjnl-2021-326789 Taketani, 2020, Genetic circuit design automation for the gut resident species, Bacteroides thetaiotaomicron. Nature Biotechnology, 38, 962, 10.1038/s41587-020-0468-5 Praveschotinunt, 2019, Engineered E. coli Nissle 1917 for the delivery of matrix-tethered therapeutic domains to the gut, Nat Commun, 10 Linggang Zheng, 2022, CRISPR/Cas-Based genome editing for human gut commensal Bacteroides species, ACS Synth Biol, 11, 464, 10.1021/acssynbio.1c00543 Cubillos-Ruiz, 2022, An engineered live biotherapeutic for the prevention of antibiotic-induced dysbiosis, Nat Biomed Eng, 6, 910, 10.1038/s41551-022-00871-9 Kurkipuro, 2022, Four in one—combination therapy using live Lactococcus lactis expressing three therapeutic proteins for the treatment of chronic non-healing wounds, PLoS One, 17, 10.1371/journal.pone.0264775 Suman Pradhan, 2020, Probiotic properties of Escherichia coli Nissle in human instestinal organoids, Journal of American Society for Microbiology, 11 Leventhal, 2020, Immunotherapy with engineered bacteria by targeting the STING pathway for anti-tumor immunity, Nat Commun, 11 Dimopoulou, 2023, Licht:An engineered Escherichia coli Nissle 1917 increase the production of indole lactic acid in the gut, FEMS Microbiol Lett, 370, 1, 10.1093/femsle/fnad027 Hayashi, 2021, Cas9-Assisted Biological Containment of a Genetically Engineered Human Commensal Bacterium and Genetic Elements, bioRxiv Kangsan Kim, 2021, Engineering Bacteroides thetaiotaomicron to produce non-native butyrate based on genome-scale metabolic model-guided design, Metab Eng, 68, 174, 10.1016/j.ymben.2021.10.005 Wexler, 2007, Bacteroides: the good, the bad, and the Nitty-gritty, Clin Microbiol Rev, 20, 593, 10.1128/CMR.00008-07 Cubillos-Ruiz, 2021, Engineering living therapeutics with synthetic biology, Nat Rev Drug Discov, 20, 941, 10.1038/s41573-021-00285-3 Tan, 2020, Engineered live biotherapeutics: progress and challenges, Biotechnol J, 15, 2000155, 10.1002/biot.202000155 Gencay, 2023, Engineered phage with antibacterial CRISPR–Cas selectively reduce E. coli burden in mice, Nat Biotechnol, 10.1038/s41587-023-01759-y Bhowmick, 2023, A CcdB toxin-derived peptide acts as a broad-spectrum antibacterial therapeutic in infected mice, EMBO Rep, 10.15252/embr.202255338 Mazé, 2020, Artificial signaling in mammalian cells enabled by prokaryotic two-component system, Nat Chem Biol, 16, 179, 10.1038/s41589-019-0429-9 Rondon, 2019, Engineering a new class of anti-LacI transcription factors with alternate DNA recognition, ACS Synth Biol, 8, 307, 10.1021/acssynbio.8b00324 Isabella, 2018, Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuria, Nat Biotechnol, 36, 857, 10.1038/nbt.4222 Piñero-Lambea, 2015, Fernández LÁ: programming controlled adhesion of E. coli to target surfaces, cells, and tumors with synthetic adhesins, ACS Synth Biol, 4, 463, 10.1021/sb500252a